Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahil N Ganesh

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nano Today|September 26, 2018
Colloidal aggregation: from screening nuisance to formulation nuanceAhil N Ganesh, Eric N Donders, Brian K Shoichet, et al.
Biomaterials|February 6, 2017
Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse modelJennifer Logie, Ahil N Ganesh, Ahmed M Aman, et al.
ACS Applied Materials & Interfaces|March 21, 2017
A New Spin on Antibody-Drug Conjugates: Trastuzumab-Fulvestrant Colloidal Drug Aggregates Target HER2-Positive CellsAhil N Ganesh, Christopher K McLaughlin, Da Duan, et al.
ACS Chemical Biology|January 8, 2016
Stable Colloidal Drug Aggregates Catch and Release Active EnzymesChristopher K McLaughlin, Da Duan, Ahil N Ganesh, et al.
ACS Chemical Biology|June 28, 2019
Triggered Release Enhances the Cytotoxicity of Stable Colloidal Drug AggregatesEric N Donders, Ahil N Ganesh, Hayarpi Torosyan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 11, 2023
Synthetic Ionizable Colloidal Drug Aggregates Enable Endosomal DisruptionEric N Donders, Kai V Slaughter, Christian Dank, et al.
ACS Chemical Biology|January 9, 2014
Colloidal drug formulations can explain "bell-shaped" concentration-response curvesShawn C Owen, Allison K Doak, Ahil N Ganesh, et al.
Molecular Pharmaceutics|May 16, 2017
Leveraging Colloidal Aggregation for Drug-Rich Nanoparticle FormulationsAhil N Ganesh, Jennifer Logie, Christopher K McLaughlin, et al.
ACS Chemical Biology|March 7, 2019
Colloidal Drug Aggregate Stability in High Serum Conditions and Pharmacokinetic ConsequenceAhil N Ganesh, Ahmed Aman, Jennifer Logie, et al.
Human Gene Therapy|February 9, 2026
Systemic Administration of AAV9-G266A with Focused Ultrasound Enables Robust Brain Transduction with Minimal Liver TransductionAndrew T Nelson, Aidan Smith, Colleen T Curley, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nano Today|September 26, 2018
Colloidal aggregation: from screening nuisance to formulation nuanceAhil N Ganesh, Eric N Donders, Brian K Shoichet, et al.
Biomaterials|February 6, 2017
Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse modelJennifer Logie, Ahil N Ganesh, Ahmed M Aman, et al.
ACS Applied Materials & Interfaces|March 21, 2017
A New Spin on Antibody-Drug Conjugates: Trastuzumab-Fulvestrant Colloidal Drug Aggregates Target HER2-Positive CellsAhil N Ganesh, Christopher K McLaughlin, Da Duan, et al.
ACS Chemical Biology|January 8, 2016
Stable Colloidal Drug Aggregates Catch and Release Active EnzymesChristopher K McLaughlin, Da Duan, Ahil N Ganesh, et al.
ACS Chemical Biology|June 28, 2019
Triggered Release Enhances the Cytotoxicity of Stable Colloidal Drug AggregatesEric N Donders, Ahil N Ganesh, Hayarpi Torosyan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 11, 2023
Synthetic Ionizable Colloidal Drug Aggregates Enable Endosomal DisruptionEric N Donders, Kai V Slaughter, Christian Dank, et al.
ACS Chemical Biology|January 9, 2014
Colloidal drug formulations can explain "bell-shaped" concentration-response curvesShawn C Owen, Allison K Doak, Ahil N Ganesh, et al.
Molecular Pharmaceutics|May 16, 2017
Leveraging Colloidal Aggregation for Drug-Rich Nanoparticle FormulationsAhil N Ganesh, Jennifer Logie, Christopher K McLaughlin, et al.
ACS Chemical Biology|March 7, 2019
Colloidal Drug Aggregate Stability in High Serum Conditions and Pharmacokinetic ConsequenceAhil N Ganesh, Ahmed Aman, Jennifer Logie, et al.
Human Gene Therapy|February 9, 2026
Systemic Administration of AAV9-G266A with Focused Ultrasound Enables Robust Brain Transduction with Minimal Liver TransductionAndrew T Nelson, Aidan Smith, Colleen T Curley, et al.
Pageof 2